Subscriber tool

Deviation Investigation Framework Builder

Describe your manufacturing deviation and get a complete investigation framework - scope determination, root cause methodology, CAPA structure and effectiveness check criteria - tailored to your specific deviation type and regulatory context.

Addresses the number one FDA 483 citation. Failure to thoroughly investigate unexplained discrepancies under 21 CFR 211.192 has been the top or second-ranked cGMP citation for four consecutive years. This tool generates a structured framework built from current FDA inspection expectations and real enforcement data.

Step 1 - Describe the deviation

The more detail you provide, the more specific and useful your framework will be.
0/1500

Step 2 - Investigation context

This helps calibrate the depth and urgency of the framework.
0/600

Framework generation takes 20 to 35 seconds.

⚙

Building your framework

Analysing deviation type and regulatory context

Investigation Framework

Deviation summary and regulatory classification
1
Scope determination and immediate actions
▼
2
Root cause analysis methodology
▼
3
CAPA structure and implementation
▼
4
Effectiveness check criteria
▼
5
Documentation requirements and investigation report
▼
6
Regulatory notifications and escalation criteria
▼
This framework is a structured starting point based on current cGMP requirements and FDA inspection expectations. All investigation conclusions, CAPA decisions and regulatory notification determinations must be made by qualified pharmaceutical professionals with site-specific knowledge. Always verify against your own SOPs and quality system requirements.

GMPify courses relevant to this deviation

Full catalog access from day one. Every course built from primary regulatory sources.

Subscribe to access full catalog →